CA2174240A1 - Utilisation de penciclorine dans le traitement des algies post-therapeutiques - Google Patents

Utilisation de penciclorine dans le traitement des algies post-therapeutiques

Info

Publication number
CA2174240A1
CA2174240A1 CA002174240A CA2174240A CA2174240A1 CA 2174240 A1 CA2174240 A1 CA 2174240A1 CA 002174240 A CA002174240 A CA 002174240A CA 2174240 A CA2174240 A CA 2174240A CA 2174240 A1 CA2174240 A1 CA 2174240A1
Authority
CA
Canada
Prior art keywords
treatment
acyclovir
composition according
patients
phn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002174240A
Other languages
English (en)
Inventor
Ronald James Boon
David Ronald John Griffin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2174240A1 publication Critical patent/CA2174240A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Catching Or Destruction (AREA)

Abstract

Selon l'invention, on utilise l'acyclovir ou un bioprécurseur ou un sel pharmaceutiquement acceptable, ou un ester phosphorique et/ou un dérivé acyle de l'une de ces substances, dans la préparation d'un médicament utilisé dans le traitement (y compris la prophylaxie) des algies post-zostériennes (PHN).
CA002174240A 1993-10-16 1994-10-14 Utilisation de penciclorine dans le traitement des algies post-therapeutiques Abandoned CA2174240A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939321394A GB9321394D0 (en) 1993-10-16 1993-10-16 Pharmaceuticals
GB9321394.0 1993-10-16

Publications (1)

Publication Number Publication Date
CA2174240A1 true CA2174240A1 (fr) 1995-04-27

Family

ID=10743678

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002174240A Abandoned CA2174240A1 (fr) 1993-10-16 1994-10-14 Utilisation de penciclorine dans le traitement des algies post-therapeutiques

Country Status (9)

Country Link
EP (1) EP0723448A1 (fr)
JP (1) JPH09503779A (fr)
AU (1) AU7860394A (fr)
BE (1) BE1007586A3 (fr)
CA (1) CA2174240A1 (fr)
FR (1) FR2711061B1 (fr)
GB (2) GB9321394D0 (fr)
WO (1) WO1995011027A1 (fr)
ZA (1) ZA948065B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000002592A1 (fr) * 1998-07-09 2000-01-20 Warner-Lambert Company Composition pharmaceutique renfermant des analogues d'acide gamma-aminobutyrique (gaba) et un agent antiviral aux fins du traitement de syndromes radiculoganglionnaires

Also Published As

Publication number Publication date
FR2711061B1 (fr) 1995-12-01
GB9420754D0 (en) 1994-11-30
ZA948065B (en) 1996-04-10
GB2282759A (en) 1995-04-19
EP0723448A1 (fr) 1996-07-31
GB9321394D0 (en) 1993-12-08
JPH09503779A (ja) 1997-04-15
WO1995011027A1 (fr) 1995-04-27
FR2711061A1 (fr) 1995-04-21
BE1007586A3 (fr) 1995-08-16
AU7860394A (en) 1995-05-08

Similar Documents

Publication Publication Date Title
McGill et al. Intravenous acyclovir in acute herpes zoster infection
CA2836480A1 (fr) Methodes de traitement de la sclerose en plaques et de conservation et/ou d'augmentation de la teneur en myeline
EP0296620A2 (fr) Utilisation des sels d'acide n-acétylneuraminique pour la fabrication d'un médicament pour décongester la membrane pituitaire
US4315001A (en) 2-Deoxy glucose as an antiviral agent against herpes simplex
JPS59130223A (ja) 相乗作用を示す抗ヘルペス組成物
NZ504656A (en) Substituted aminomethyl-chromans are used for the regenerative treatment of neurological conditions which are the sequelae of damage due to surgical intervention, exposure to toxic agents, infections, tumours, and other diseases and conditions
JPH10158169A (ja) 塩化トロスピウムを含んだ医薬製剤、その調整方法および使用方法
JPH0320222A (ja) 脳内虚血症治療剤
US5952340A (en) Use of granisetron for the treatment of postoperative nausea and vomiting
JPH06263644A (ja) リチウム治療剤
EP0502048B1 (fr) Utilisation de la cafeine dans le traitement des infections relatives a l'herpes "bouton de fievre"
CA2174240A1 (fr) Utilisation de penciclorine dans le traitement des algies post-therapeutiques
US6512011B1 (en) Bupropion to treat herpes viral diseases
CA2065889C (fr) Augmentation du debit choroidien
IE51737B1 (en) Topical formulations of 3-deazaadenosine
US5486506A (en) Method for treating cardiac inotropic irregularities
US4436732A (en) Medicated compound for treating diseases infected by virus of the herpes group
KR100608963B1 (ko) 프로필렌 글리콜 및 이소프로필 알칸산 에스테르를포함하는 항바이러스 제제
HU226472B1 (en) Pharmaceutical preparation containing penciclorin for the treatment of post-herpetic neuralgia
US7618950B2 (en) Method for treatment and prevention of herpes zoster by topical application
WO2004069168A2 (fr) Nouvelles combinaisons de medicaments contre l'herpes
US20040029973A1 (en) Bupropion to treat viral diseases
JPH09506883A (ja) 薬 剤
JPH0662442B2 (ja) 点鼻薬
JPH09143096A (ja) ウィルス疾患用医薬組成物

Legal Events

Date Code Title Description
FZDE Dead